Market Research Logo

Portugal Pharmaceuticals and Healthcare Report Q4 2017

Portugal Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Portugal's pharmaceutical market will expand modestly over the forecast period, observing a slightly improved growth trend relative to the previous five years. Although the improved economic outlook should, in principle, generate commercial opportunities for drugmakers and healthcare providers, public hospitals' debt will continue to translate into high risks of payment delays to pharmaceutical companies operating in the country. In fact, industry risks will deter investment in the pharmaceutical sector in the near term, limiting the modest competitive gains from piecemeal economic reforms and internal devaluation.

Headline Expenditure Projections

Pharmaceuticals: EUR3.60bn (USD3.98bn) in 2016 to EUR3.63bn (USD3.99bn) in 2017; +0.9% in local currency and +0.3% in US dollar terms. Forecast revised upwards from last quarter.

Healthcare: EUR17.03bn (USD18.84bn) in 2016 to EUR17.47bn (USD19.21bn) in 2017; +2.6% in local currency and +2.0% in US dollar terms. Forecast revised upwards from last quarter.

Latest Updates

In August 2017, Prime Minister António Costa promised an increase in spending on health and education in the state budget for 2018.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Portugal 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Portugal 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Portugal 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Portugal 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Portugal 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Portugal 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Portugal 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Portugal 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Portugal 2015-2021)
Industry Risk/Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Portugal 2011-2016)
Table: Healthcare Personnel (Portugal 2011-2016)
Table: Healthcare Activity (Portugal 2011-2016)
Research and Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Generic Drugmakers
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Bial
Bluepharma
Hovione
Medinfar
Demographic Forecast
Table: Population Headline Indicators (Portugal 1990-2025)
Table: Key Population Ratios (Portugal 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Portugal 1990-2025)
Table: Population By Age Group (Portugal 1990-2025)
Table: Population By Age Group % (Portugal 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report